Form 8-K - Current report:
SEC Accession No. 0001641172-25-026168
Filing Date
2025-09-02
Accepted
2025-09-02 09:29:58
Documents
15
Period of Report
2025-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46154
2 EX-4.1 ex4-1.htm EX-4.1 26310
3 EX-4.2 ex4-2.htm EX-4.2 24909
  Complete submission text file 0001641172-25-026168.txt   320720

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20250902.xsd EX-101.SCH 3768
5 XBRL DEFINITION FILE biaf-20250902_def.xml EX-101.DEF 26601
6 XBRL LABEL FILE biaf-20250902_lab.xml EX-101.LAB 36623
7 XBRL PRESENTATION FILE biaf-20250902_pre.xml EX-101.PRE 25225
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5766
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251283306
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)